Kaposi sarcoma (KS) gained public attention as an AIDS-defining malignancy; its
appearance on the skin was a highly stigmatizing sign of HIV infection during the height of …

In 1872, Moritz Kaposi, a Hungarian dermatologist, described five men with aggressive
“idiopathic multiple pigmented sarcomas of the skin.” 1 One patient died of gastrointestinal …

The genome of the Kaposi sarcoma-associated herpesvirus (KSHV or HHV8) was mapped
with cosmid and phage genomic libraries from the BC-1 cell line. Its nucleotide sequence …

As newer immunosuppressive regimens have steadily reduced the incidence of acute
rejection and have extended the life expectancy of allograft recipients, posttransplant …

Primary effusion lymphoma (PEL) cells harbor Kaposi's sarcoma–associated herpesvirus
(KSHV) episomes and express a KSHV-encoded latency-associated nuclear antigen …

Background To clarify which types of cancer result from AIDS, we compared the cancer
experiences of people with AIDS with those of the general population by matching …

Kaposi's sarcoma (KS) is the leading neoplasm of AIDS patients, and HIV infection is known
to be a major risk factor for its development1, 2. However, KS can occur in the absence of …

The linkage of Kaposi sarcoma (KS) to infection by a novel human herpesvirus (Kaposi
sarcoma–associated herpesvirus [KSHV]) is one of the great successes of contemporary …

Herpesviruses exist in two states, latency and a lytic productive cycle. Here we identify an
immediate-early gene encoded by Kaposi's sarcoma-associated herpesvirus (KSHV)/human …

A major controversy regarding Kaposi's sarcoma–associated herpesvirus (KSHV or HHV8)
1, 2 is whether or not it is a ubiquitous infection of humans3, 4. Immunoassays based on …